3.4.22.65: peptidase 1 (mite)
This is an abbreviated version!
For detailed information about peptidase 1 (mite), go to the full flat file.
Word Map on EC 3.4.22.65
-
3.4.22.65
-
allergic
-
asthma
-
ige
-
dermatophagoides
-
pteronyssinus
-
children
-
home
-
asthmatic
-
atopic
-
farinae
-
airway
-
indoor
-
immunotherapy
-
mattress
-
bronchial
-
rhinitis
-
inhale
-
prick
-
allergen-specific
-
floor
-
carpet
-
bedroom
-
dermatitis
-
humid
-
hyperresponsiveness
-
airborne
-
household
-
houses
-
cockroach
-
aeroallergens
-
vacuum
-
wheeze
-
house-dust
-
ige-binding
-
cleaner
-
ras
-
blomia
-
anti-der
-
allergen-induced
-
rhinoconjunctivitis
-
component-resolved
-
mite-induced
-
radioallergosorbent
-
diagnostics
-
hdm-induced
-
hypoallergenic
-
pharmacology
-
nonatopic
-
medicine
-
wheal
-
immunocap
-
dander
-
skin-prick
-
drug development
- 3.4.22.65
-
allergic
- asthma
- ige
- dermatophagoides
- pteronyssinus
- children
-
home
-
asthmatic
-
atopic
- farinae
- airway
-
indoor
-
immunotherapy
-
mattress
- bronchial
- rhinitis
-
inhale
-
prick
-
allergen-specific
-
floor
-
carpet
-
bedroom
- dermatitis
-
humid
-
hyperresponsiveness
-
airborne
-
household
-
houses
- cockroach
-
aeroallergens
-
vacuum
-
wheeze
-
house-dust
-
ige-binding
-
cleaner
- ras
- blomia
-
anti-der
-
allergen-induced
-
rhinoconjunctivitis
-
component-resolved
-
mite-induced
-
radioallergosorbent
- diagnostics
-
hdm-induced
-
hypoallergenic
- pharmacology
-
nonatopic
- medicine
-
wheal
-
immunocap
-
dander
-
skin-prick
- drug development
Reaction
broad endopeptidase specificity =
Synonyms
allergen Der f 1, allergen Der f1, allergen Der p, allergen Der p 1, allergen Der p1, CO1.073, Der f 1, Der f1, Der p 1, Der p 7, Der p1, dust mite allergen Der p 7, dust mite peptidase allergen Der p 1, house dust mite allergen, house dust mite allergens, major house dust mite allergen, mite allergen, mite major group 1 allergens, pro-Der f1, ProDer f 1, ProDer p 1
ECTree
Advanced search results
Inhibitors
Inhibitors on EC 3.4.22.65 - peptidase 1 (mite)
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
(3S)-3-([N-[(2S)-3,3-dimethyl-2-(1-oxo-1,3-dihydro-2H-isoindol-2-yl)butanoyl]-L-alanyl]amino)-4-methyl-2-oxo-N-(4-sulfamoylbenzyl)pentanamide
-
(3S)-N-benzyl-3-([N-[(2S)-3,3-dimethyl-2-(1-oxo-1,3-dihydro-2H-isoindol-2-yl)butanoyl]-L-alanyl]amino)-4-methyl-2-oxopentanamide
-
(3S)-N-[4-[(dimethylamino)methyl]benzyl]-3-([N-[(2S)-3,3-dimethyl-2-(1-oxo-1,3-dihydro-2H-isoindol-2-yl)butanoyl]-L-alanyl]amino)-4-methyl-2-oxopentanamide
-
3-methyl-N-(naphthalen-1-ylcarbonyl)-L-valyl-N-[(3S)-1-(cyclohexylamino)-4-methyl-1,2-dioxopentan-3-yl]-L-alaninamide
-
3-methyl-N-(pyridin-4-ylcarbonyl)-L-valyl-N-[(3S)-1-(cyclohexylamino)-4-methyl-1,2-dioxopentan-3-yl]-L-alaninamide
-
3-methyl-N-(quinolin-4-ylcarbonyl)-L-valyl-N-[(3S)-1-(benzylamino)-4-methyl-1,2-dioxopentan-3-yl]-L-alaninamide
-
3-methyl-N-(quinolin-4-ylcarbonyl)-L-valyl-N-[(3S)-1-(cyclohexylamino)-4-methyl-1,2-dioxopentan-3-yl]-L-alaninamide
-
3-methyl-N-(quinolin-4-ylcarbonyl)-L-valyl-N-[(3S)-4-methyl-1,2-dioxo-1-([2-oxo-2-[4-(propan-2-yl)piperazin-1-yl]ethyl]amino)pentan-3-yl]-L-alaninamide
-
3-methyl-N-[(1-methylpiperidin-4-yl)carbonyl]-L-valyl-N-[(3S)-1-(benzylamino)-4-methyl-1,2-dioxopentan-3-yl]-L-alaninamide
-
4-([[(3S)-3-([N-[(2S)-3,3-dimethyl-2-(1-oxo-1,3-dihydro-2H-isoindol-2-yl)butanoyl]-L-alanyl]amino)-4-methyl-2-oxopentanoyl]amino]methyl)-N-methylbenzamide
-
chestnut cystatin
-
inhibits the enzyme and greatly increases the larval mortality
-
Der p 1 allergen
-
ADZ 50,000, irreversible inactivation, active site titrant
-
Der p 1 prodomain
-
PP-02, recombinant, apparently competitive
-
Der p 1 propeptide
the propeptide of 80 amino acids plays an essential role in zymogen folding (as an intramolecular chaperone) and in the inhibition of its own enzymatic activity
-
Der p 1 propiece
-
potent competitive inhibitor of Der p 1. The Der p 1 propiece behaves as a substrate and is fully degraded during this interaction
-
N-(naphthalen-1-ylcarbonyl)-L-phenylalanyl-N-[(3S)-4-methyl-1-[[2-(4-methylpiperazin-1-yl)-2-oxoethyl]amino]-1,2-dioxopentan-3-yl]-L-alaninamide
-
N-benzoyl-3-methyl-L-valyl-N-[(3S)-1-(benzylamino)-4-methyl-1,2-dioxopentan-3-yl]-L-alaninamide
-
N-benzoyl-3-methyl-L-valyl-N-[(3S)-1-(cyclohexylamino)-4-methyl-1,2-dioxopentan-3-yl]-L-alaninamide
-
N-benzoyl-3-methyl-L-valyl-N-[(3S)-1-(cyclopropylamino)-4-methyl-1,2-dioxopentan-3-yl]-L-alaninamide
-
N-benzoyl-3-methyl-L-valyl-N-[(3S)-1-([4-[(dimethylamino)methyl]benzyl]amino)-4-methyl-1,2-dioxopentan-3-yl]-L-alaninamide
-
N-benzoyl-3-methyl-L-valyl-N-[(3S)-1-amino-4-methyl-1,2-dioxopentan-3-yl]-L-alaninamide
-
N-benzoyl-3-methyl-L-valyl-N-[(3S)-4-methyl-1,2-dioxo-1-[(1H-pyrazol-4-ylmethyl)amino]pentan-3-yl]-L-alaninamide
-
N-benzoyl-3-methyl-L-valyl-N-[(3S)-4-methyl-1,2-dioxo-1-[(4-sulfamoylbenzyl)amino]pentan-3-yl]-L-alaninamide
-
N-benzoyl-3-methyl-L-valyl-N-[(3S)-4-methyl-1,2-dioxo-1-[[(1R)-1-phenylethyl]amino]pentan-3-yl]-L-alaninamide
-
N-benzoyl-3-methyl-L-valyl-N-[(3S)-4-methyl-1,2-dioxo-1-[[(1S)-1-phenylethyl]amino]pentan-3-yl]-L-alaninamide
-
N-benzoyl-3-methyl-L-valyl-N-[(3S)-4-methyl-1,2-dioxo-1-[[4-(trifluoromethyl)benzyl]amino]pentan-3-yl]-L-alaninamide
-
N-benzoyl-3-methyl-L-valyl-N-[(3S)-4-methyl-1-(methylamino)-1,2-dioxopentan-3-yl]-L-alaninamide
-
N-benzoyl-3-methyl-L-valyl-N-[(3S)-4-methyl-1-[[2-(4-methylpiperazin-1-yl)-2-oxoethyl]amino]-1,2-dioxopentan-3-yl]-L-alaninamide
-
N-benzoyl-b,b-dimethyl-L-phenylalanyl-N-[(3S)-1-(benzylamino)-4-methyl-1,2-dioxopentan-3-yl]-L-alaninamide
-
N-benzoyl-L-phenylalanyl-N-[(3S)-1,2-dioxo-1-(pyrrolidin-1-yl)heptan-3-yl]-L-alaninamide
-
N-benzoyl-L-phenylalanyl-N-[(3S)-1-(benzylamino)-4-methyl-1,2-dioxopentan-3-yl]-L-alaninamide
-
N-benzoyl-L-phenylalanyl-N-[(3S)-1-(cyclohexylamino)-1,2-dioxoheptan-3-yl]-L-alaninamide
-
N-benzoyl-L-phenylalanyl-N-[(3S)-1-(cyclohexylamino)-4,4-dimethyl-1,2-dioxopentan-3-yl]-L-alaninamide
-
N-benzoyl-L-phenylalanyl-N-[(3S)-1-(cyclohexylamino)-4-methyl-1,2-dioxopentan-3-yl]-L-alaninamide
-
N-benzoyl-L-phenylalanyl-N-[(3S)-1-(cyclohexylamino)-4-methyl-1,2-dioxopentan-3-yl]-L-norvalinamide
-
N-benzoyl-L-phenylalanyl-N-[(3S)-1-[[2-(3,4-dihydroisoquinolin-2(1H)-yl)-2-oxoethyl]amino]-4-methyl-1,2-dioxopentan-3-yl]-L-alaninamide
-
N-benzoyl-L-phenylalanyl-N-[(3S)-1-[[2-(4,4-dimethylpiperazin-4-ium-1-yl)-2-oxoethyl]amino]-4-methyl-1,2-dioxopentan-3-yl]-L-alaninamide
-
N-benzoyl-L-phenylalanyl-N-[(3S)-2-oxo-1-(pyrrolidin-1-yl)heptan-3-yl]-L-alaninamide
-
N-benzoyl-L-phenylalanyl-N-[(3S)-4-methyl-1,2-dioxo-1-(tetrahydro-2H-pyran-4-ylamino)pentan-3-yl]-L-alaninamide
-
N-benzoyl-L-phenylalanyl-N-[(3S)-4-methyl-1,2-dioxo-1-([2-oxo-2-[4-(propan-2-yl)piperazin-1-yl]ethyl]amino)pentan-3-yl]-L-alaninamide
-
N-benzoyl-L-phenylalanyl-N-[(3S)-4-methyl-1,2-dioxo-1-[[2-oxo-2-(piperidin-1-yl)ethyl]amino]pentan-3-yl]-L-alaninamide
-
N-benzoyl-L-phenylalanyl-N-[(3S)-4-methyl-1-[(1-methylpiperidin-4-yl)amino]-1,2-dioxopentan-3-yl]-L-alaninamide
-
N-benzoyl-L-phenylalanyl-N-[(3S)-4-methyl-1-[[(2S)-1-(4-methylpiperazin-1-yl)-1-oxopropan-2-yl]amino]-1,2-dioxopentan-3-yl]-L-alaninamide
-
N-benzoyl-L-phenylalanyl-N-[(3S)-4-methyl-1-[[2-(4-methylpiperazin-1-yl)-2-oxoethyl]amino]-1,2-dioxopentan-3-yl]-L-alaninamide
-
N-benzoyl-L-phenylalanyl-N-[(3S)-4-methyl-1-[[2-(morpholin-4-yl)-2-oxoethyl]amino]-1,2-dioxopentan-3-yl]-L-alaninamide
-
N-benzoyl-L-valyl-N-[(3S)-1-(benzoyloxy)-2-oxoheptan-3-yl]-L-alaninamide
irreversible inhibitor
N-[(1,1-dimethylpiperidinium-4-yl)carbonyl]-3-methyl-L-valyl-N-[(3S)-1-(benzylamino)-4-methyl-1,2-dioxopentan-3-yl]-L-alaninamide
-
N-[(1S)-2-[[(2S)-1-[[(3S)-4-methyl-1-[[2-(4-methylpiperazin-1-yl)-2-oxoethyl]amino]-1,2-dioxopentan-3-yl]amino]-1-oxopropan-2-yl]amino]-2-oxo-1-(tricyclo[3.3.1.13,7]dec-1-yl)ethyl]benzamide
-
N-[(3,5-dimethyl-1H-pyrazol-4-yl)carbonyl]-3-methyl-L-valyl-N-[(3S)-1-(benzylamino)-4-methyl-1,2-dioxopentan-3-yl]-L-alaninamide
-
PTL11028
-
a highly potent and specific inhibitor, being effective against both purified protease and Der p 1 within HDM extract
-
sweat inhibitor, upregulation of IL-8 secretion by stimulation of human keratinocytes by Der f 1 is blocked
-
E-64
-
trans-epoxysuccinyl L-leucylamido (4-guanidine) butane, 0.01 mM, complete inhibition of interleukine production in A549 epithelial cells
E-64
-
cysteine protease-specific inhibitor, complete inhibition
E-64
cysteine protease-specific inhibitor, 0.1 mM, complete inhibition
-
Der f1 from Dermatophagoides farinae is highly susceptible, Der p 1 from Dermatophagoides pteronyssinus is not affected by chestnut cystatin. Der p 1 inactivates chestnut chystatin by a specific proteolytic cleavage between Gly6 and Val7
-
additional information
inhibition efficiency in vivo, overview
-